Hydrogen peroxide impairs GRK2 translation via a calpain-dependent and cdk1-mediated pathway

Cellular Signalling

Volumn 19, Issue 2, 2007, Pages 269-277

  Cobelens, P M ^a   Kavelaars, A ^b   Heijnen, C J ^b   Ribas, C ^a   Mayor Jr , F ^a   Penela, P ^a  

^a CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Glia; GRK2; Oxidative stress; Protein translation

Indexed keywords

CALPAIN; CYCLIN DEPENDENT KINASE 1; G PROTEIN COUPLED RECEPTOR KINASE 2; HYDROGEN PEROXIDE; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PROTEINASE INHIBITOR;

ANIMAL CELL; ARTICLE; BRAIN HYPOXIA; BRAIN ISCHEMIA; DEGRADATION KINETICS; DOWN REGULATION; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME REGULATION; GLIA CELL; GLIOMA CELL; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TRANSLATION REGULATION;

ANIMALS; BETA-ADRENERGIC RECEPTOR KINASE; CALPAIN; CDC2 PROTEIN KINASE; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GLIOMA; HYDROGEN PEROXIDE; OXIDATIVE STRESS; PROTEIN BIOSYNTHESIS; PROTEIN KINASES; RATS; SIGNAL TRANSDUCTION;

EID: 33845685097     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellsig.2006.06.009     Document Type: Article

References (39)

1. Penela P., Ribas C., and Mayor Jr. F. Cell. Signal. 15 11 (2003) 973
2. Ferguson S.S. Pharmacol. Rev. 53 1 (2001) 1
3. Gainetdinov R.R., Premont R.T., Bohn L.M., Lefkowitz R.J., and Caron M.G. Annu. Rev. Neurosci. 27 (2004) 107
4. Metaye T., Gibelin H., Perdrisot R., and Kraimps J.L. Cell. Signal. 17 8 (2005) 917
5. Erdtmann-Vourliotis M., Mayer P., Ammon S., Riechert U., and Hollt V. Brain Res. Mol. Brain Res. 95 1-2 (2001) 129
6. Murga C., Penela P., Zafra F., and Mayor Jr. F. Neuroscience 87 3 (1998) 631
7. Penela P., Alvarez-Dolado M., Munoz A., and Mayor Jr. F. Eur. J. Biochem. 267 14 (2000) 4390
8. Lombardi M.S., Kavelaars A., Schedlowski M., Bijlsma J.W., Okihara K.L., Van de Pol M., Ochsmann S., Pawlak C., Schmidt R.E., and Heijnen C.J. FASEB J. 13 6 (1999) 715
9. Lombardi M.S., Kavelaars A., Cobelens P.M., Schmidt R.E., Schedlowski M., and Heijnen C.J. J. Immunol. 166 3 (2001) 1635
10. Vroon A., Kavelaars A., Limmroth V., Lombardi M.S., Goebel M.U., Van Dam A.M., Caron M.G., Schedlowski M., and Heijnen C.J. J. Immunol. 174 7 (2005) 4400
11. Vroon A., Lombardi M.S., Kavelaars A., and Heijnen C.J. J. Neuroimmunol. 137 1-2 (2003) 79
12. Lombardi M.S., van den Tweel E., Kavelaars A., Groenendaal F., van Bel F., and Heijnen C.J. Stroke 35 4 (2004) 981
13. Penela P., Ruiz-Gomez A., Castano J.G., and Mayor Jr. F. J. Biol. Chem. 273 52 (1998) 35238
14. Penela P., Elorza A., Sarnago S., and Mayor Jr. F. EMBO J. 20 18 (2001) 5129
15. Elorza A., Penela P., Sarnago S., and Mayor Jr. F. J. Biol. Chem. 278 31 (2003) 29164
16. Lombardi M.S., Kavelaars A., Penela P., Scholtens E.J., Roccio M., Schmidt R.E., Schedlowski M., Mayor Jr. F., and Heijnen C.J. Mol. Pharmacol. 62 2 (2002) 379
17. Mhatre M., Floyd R.A., and Hensley K. J. Alzheimer's Dis. 6 2 (2004) 147
18. Crack P.J., and Taylor J.M. Free Radic. Biol. Med. 38 11 (2005) 1433
19. Vannucci S.J., and Hagberg H. J. Exp. Biol. 207 Pt 18 (2004) 3149
20. Klein J.A., and Ackerman S.L. J. Clin. Invest. 111 6 (2003) 785
21. Holcik M., and Sonenberg N. Nat. Rev., Mol. Cell Biol. 6 4 (2005) 318
22. Gottesfeld J.M., and Forbes D.J. Trends Biochem. Sci. 22 6 (1997) 197
23. Heesom K.J., Gampel A., Mellor H., and Denton R.M. Curr. Biol. 11 17 (2001) 1374
24. Shah O.J., Ghosh S., and Hunter T. J. Biol. Chem. 278 18 (2003) 16433
25. Shi J., Feng Y., Goulet A.C., Vaillancourt R.R., Sachs N.A., Hershey J.W., and Nelson M.A. J. Biol. Chem. 278 7 (2003) 5062
26. Tee A.R., and Blenis J. Semin. Cell Dev. Biol. 16 1 (2005) 29
27. Elorza A., Sarnago S., and Mayor Jr. F. Mol. Pharmacol. 57 4 (2000) 778
28. Guo X., Gerl R.E., and Schrader J.W. J. Biol. Chem. 278 25 (2003) 22237
29. Choi J.S., Kim H.Y., Chung J.W., Chun M.H., Kim S.Y., Yoon S.H., and Lee M.Y. Neurosci. Lett. 380 1-2 (2005) 1
30. Koistinaho J., and Hokfelt T. NeuroReport 8 2 (1997) i
31. Neumar R.W., DeGracia D.J., White B.C., McDermott P.J., Evans D.R., and Krause G.S. J. Neurochem. 65 3 (1995) 1391
32. Ray S.K., Wilford G.G., Crosby C.V., Hogan E.L., and Banik N.L. Brain Res. 829 1-2 (1999) 18
33. Kubbutat M.H., and Vousden K.H. Mol. Cell. Biol. 17 1 (1997) 460
34. Porter L.A., and Donoghue D.J. Prog. Cell Cycle Res. 5 (2003) 335
35. Patel S., Van Der Kaay J., and Sutherland C. Biochem. J. 365 Pt 2 (2002) 537
36. Patel J., McLeod L.E., Vries R.G., Flynn A., Wang X., and Proud C.G. Eur. J. Biochem. 269 12 (2002) 3076
37. Alirezaei M., Marin P., Nairn A.C., Glowinski J., and Premont J. J. Neurochem. 76 4 (2001) 1080
38. De Keyser J., Zeinstra E., Mostert J., and Wilczak N. Trends Pharmacol. Sci. 25 2 (2004) 67
39. Feinstein D.L., Heneka M.T., Gavrilyuk V., Dello Russo C., Weinberg G., and Galea E. Neurochem. Int. 41 5 (2002) 357